
ADIL Valuation
Adial Pharmaceuticals Inc
- Overview
- Forecast
- Valuation
- Earnings
ADIL Relative Valuation
ADIL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ADIL is overvalued; if below, it's undervalued.
Historical Valuation
Adial Pharmaceuticals Inc (ADIL) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -1.79. The fair price of Adial Pharmaceuticals Inc (ADIL) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price:0.48
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
1.50
P/B
Median3y
1.76
Median5y
4.12
-92.71
FCF Yield
Median3y
-155.70
Median5y
-102.84
Competitors Valuation Multiple
The average P/S ratio for ADIL's competitors is 11.65, providing a benchmark for relative valuation. Adial Pharmaceuticals Inc Corp (ADIL) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch

PBM
Psyence Biomedical Ltd
9.990
USD
+20.94%

GNPX
Genprex Inc
0.285
USD
+11.29%

GBR
New Concept Energy Inc
0.976
USD
-1.41%

DSS
DSS Inc
1.170
USD
+21.24%

CERO
CERo Therapeutics Holdings Inc
7.420
USD
-9.84%

FORD
Forward Industries Inc
9.610
USD
-2.14%

INBS
Intelligent Bio Solutions Inc
1.900
USD
-10.38%

CHNR
China Natural Resources Inc
3.770
USD
-0.26%

SPRC
Scisparc Ltd
7.690
USD
-3.91%

LGCB
Linkage Global Inc
2.700
USD
+3.85%
FAQ

Is Adial Pharmaceuticals Inc (ADIL) currently overvalued or undervalued?
Adial Pharmaceuticals Inc (ADIL) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -1.79. The fair price of Adial Pharmaceuticals Inc (ADIL) is between NaN to NaN according to relative valuation methord.

What is Adial Pharmaceuticals Inc (ADIL) fair value?

How does ADIL's valuation metrics compare to the industry average?

What is the current P/B ratio for Adial Pharmaceuticals Inc (ADIL) as of Jul 25 2025?

What is the current FCF Yield for Adial Pharmaceuticals Inc (ADIL) as of Jul 25 2025?

What is the current Forward P/E ratio for Adial Pharmaceuticals Inc (ADIL) as of Jul 25 2025?
